Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $11.4 Million - $13.2 Million
-122,931 Reduced 44.54%
153,043 $16.3 Million
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $8.32 Million - $9.47 Million
87,279 Added 46.25%
275,974 $26.7 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $5.64 Million - $6.21 Million
61,115 Added 47.9%
188,695 $19.1 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $7.39 Million - $8.2 Million
78,017 Added 157.41%
127,580 $13 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $4.59 Million - $5.2 Million
49,563 New
49,563 $5 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $199,706 - $232,331
-2,442 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $475,468 - $525,168
-5,578 Reduced 69.55%
2,442 $223,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $1.34 Million - $1.58 Million
-16,017 Reduced 66.63%
8,020 $686,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $362,010 - $437,871
-4,637 Reduced 16.17%
24,037 $2.27 Million
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $1.67 Million - $1.85 Million
20,352 Added 244.56%
28,674 $2.49 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $673,499 - $758,134
8,322 New
8,322 $727,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $1.65 Million - $2.31 Million
-23,354 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $1.29 Million - $1.46 Million
15,296 Added 189.82%
23,354 $2.21 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $689,281 - $759,547
8,058 New
8,058 $700,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.